Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Pfizer
Pfizer
Page 34 of 37
Health
Why Biogen Is Poaching This Pfizer Exec to Head Up Its R&D Shop
By
Sy Mukherjee
April 27, 2016
Finance
Here’s How Drug Prices Actually Work
By
Lauren Silva Laughlin
April 26, 2016
Health
Allergan Struck a $3.3 Billion Alzheimer’s Drug Deal Right After Its Pfizer Merger Collapsed
By
Sy Mukherjee
April 7, 2016
Health
A Federal Judge Dismissed More Than 300 Lawsuits Against Pfizer
By
Sy Mukherjee
April 7, 2016
Finance
Why the Pfizer-Allergan Deal Was a Bad Idea From the Start
By
Alan Murray
April 6, 2016
Health
Pfizer and Allergan Scrap $160 Billion Deal
By
Reuters
April 6, 2016
Finance
Pfizer, Allergan to Mutually Terminate Merger
By
Reuters
April 6, 2016
Finance
Wall Street Is Betting the Pfizer-Allergan Deal Won’t Happen
By
Jen Wieczner
April 5, 2016
Leadership
Here’s Why Allergan Shares Are Tanking
By
Reuters
April 5, 2016
Finance
April Fools: Beware of Jokes
By
Alan Murray
April 1, 2016
Finance
Pfizer Just Got Pranked Big Time Before April Fool’s Day Even Started
By
Jen Wieczner
March 31, 2016
Health
Watchdog Says U.S. Big Pharma Isn’t Paying Enough for Breaking the Law
By
Reuters
March 31, 2016
Health
Why Teva’s $40 Billion Deal for Allergan’s Generic Drugs Is Being Delayed
By
Sy Mukherjee
March 16, 2016
Leadership
Here Are the Companies Donald Trump Would Go After as President
By
Ben Geier
March 16, 2016
Finance
Here’s How Much More Pfizer Could Save in Taxes With Allergan Deal
By
Jen Wieczner
February 26, 2016
Most Popular
Law
DOGE cancelled a $349,000 grant to replace a museum’s HVAC after ChatGPT flagged it as DEI, court documents show
By
Sasha Rogelberg
Economy
Social Security has 6 years left. The fix that sounds cruelest may be the smartest
By
Nick Lichtenberg
Success
Less than 10 out of 250 billionaires have kept their promise to give away their fortune—and a philanthropy CEO says...
By
Orianna Rosa Royle